irofulven has been researched along with Acute Promyelocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estes, L; Kelner, MJ; MacDonald, JR; McMorris, TC; Samson, KM; Trani, NA | 1 |
1 other study(ies) available for irofulven and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with topotecan.
Topics: Animals; Antineoplastic Agents; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred BALB C; Mice, Nude; Sesquiterpenes; Topotecan | 2000 |